![Murielle Lortie](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Murielle Lortie
Direktor/Vorstandsmitglied bei
PROFOUND MEDICAL CORP.
Vermögen: 36 447 $ am 31.05.2026
Profil
Murielle Lortie is currently Chairman at Bishop's University, Director at Financial Executives International Canada, Independent Director at Profound Medical Corp.
since 2020, and Director at Claridge CDPQ Gestion, Inc. Former positions include Independent Director at BELLUS Health, Inc. from 2015 to 2017; Director at Pharmascience International Ltd. from 2014 to 2017; Director at Pharmascience Barbados Ltd. from 2014 to 2017; Chief Financial Officer at Liminal BioSciences, Inc. from 2019 to 2021; Member of Ordre des Comptables Agréés du Québec; Chief Financial Officer & Vice President at Pharmascience, Inc. from 2014 to 2017; and Vice President-Finance at The Bristol-Myers Squibb Canada Co. from 2005 to 2014.
Education includes undergraduate studies at Bishop's University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.06.2026 | 5’352 ( 0.01% ) | 36 447 $ | 31.05.2026 |
Aktive Positionen von Murielle Lortie
| Unternehmen | Position | Beginn |
|---|---|---|
| PROFOUND MEDICAL CORP. | Direktor/Vorstandsmitglied | 30.11.2020 |
Financial Executives International Canada
 Financial Executives International Canada Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Direktor/Vorstandsmitglied | - |
Claridge CDPQ Gestion, Inc.
 Claridge CDPQ Gestion, Inc. Financial ConglomeratesFinance Provides investment services | Direktor/Vorstandsmitglied | - |
Bishop's University
 Bishop's University Other Consumer ServicesConsumer Services Functions as a College/University | Vorsitzender | - |
Ehemalige bekannte Positionen von Murielle Lortie
| Unternehmen | Position | Ende |
|---|---|---|
| LIMINAL BIOSCIENCES INC. | Finanzdirektor/CFO | 03.09.2021 |
Pharmascience, Inc.
 Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic and drug products | Finanzdirektor/CFO | 01.10.2017 |
Pharmascience Barbados Ltd. | Direktor/Vorstandsmitglied | 01.10.2017 |
Pharmascience International Ltd. | Direktor/Vorstandsmitglied | 01.10.2017 |
| BELLUS HEALTH | Direktor/Vorstandsmitglied | 01.01.2017 |
Ausbildung von Murielle Lortie
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
64
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
BELLUS Health, Inc.
 BELLUS Health, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for the treatment of refractory chronic disease | Health Technology |
Liminal BioSciences, Inc.
 Liminal BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops distinctive novel small molecule therapeutics for metabolic, fibrotic and inflammatory diseases | Health Technology |
Bishop's University
Bishop's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ordre des Comptables Agréés du Québec
 Ordre des Comptables Agréés du Québec Miscellaneous Commercial ServicesCommercial Services Operates as an online CPA professional order | Commercial Services |
Financial Executives International Canada
Financial Executives International Canada Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
Pharmascience, Inc.
Pharmascience, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes generic and drug products | Health Technology |
Bristol-Myers Squibb Canada Co.
 Bristol-Myers Squibb Canada Co. Pharmaceuticals: MajorHealth Technology Designs, develops and wholesales pharmaceutical services | Health Technology |
Pharmascience International Ltd. | |
Profound Medical Corp.
 Profound Medical Corp. Medical SpecialtiesHealth Technology Develops and markets medical devices focused on prostate cancer | Health Technology |
Claridge CDPQ Gestion, Inc.
Claridge CDPQ Gestion, Inc. Financial ConglomeratesFinance Provides investment services | Finance |
Pharmascience Barbados Ltd. |
